This inventor holds 2 USPTO granted patents. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 2005-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kikuchi-gun, JP (2005)
- Kumamoto-ken, JP (2006)
Company Filing History:
Years Active: 2005-2006
Title: Tomoko Watanabe: Innovator in Hematology
Introduction
Tomoko Watanabe is a prominent inventor based in Kumamoto, Japan. She has made significant contributions to the field of hematology through her innovative pharmaceutical compositions. With a total of 2 patents, her work focuses on treating and preventing bleeding disorders associated with platelet dysfunction and blood coagulation disorders.
Latest Patents
Watanabe's latest patents include two groundbreaking inventions. The first patent is titled "Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy." This invention provides a pharmaceutical composition aimed at treating bleeding disorders caused by platelet dysfunction, specifically those not linked to defects in blood coagulation factors. The composition includes a hemostatic effective amount of Factor VIII and/or von Willebrand Factor, offering a method for treating patients suffering from these disorders.
The second patent is titled "Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation." This invention presents a pharmaceutical composition that addresses hemorrhage associated with blood coagulation disorders. It comprises activated Factor VII (FVIIa) and Factor X (FX) as active ingredients. This composition is designed to be safe, highly efficacious, and easy to manage for patients experiencing hemorrhage due to blood coagulation factor deficiencies.
Career Highlights
Tomoko Watanabe is affiliated with the Chemo-Sero-Therapeutic Research Institute, where she continues to advance her research and innovations in the field of hematology. Her work has garnered attention for its potential to improve patient outcomes in managing bleeding disorders.
Collaborations
Watanabe collaborates with esteemed colleagues, including Yasushi Nakatomi and Kazuhiko Tomokiyo. Their combined expertise contributes to the development of effective treatments in the field of hematology.
Conclusion
Tomoko Watanabe's contributions to the field of hematology through her innovative patents highlight her dedication to improving patient care. Her work in developing pharmaceutical compositions for bleeding disorders showcases the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile